Adult-onset chronic progressive external ophthalmoplegia with mitochondrial myopathy is a rare mitochondrial disease characterized by adult onset of progressive external ophthalmoplegia, exercise into...
Comprehensive, easy-to-understand information about this condition
How we create this content →Helpful links for rare disease information and support
Questions that may be helpful when speaking with your healthcare team
European rare disease database
Genetic and Rare Diseases Info Center
AI-Generated Content: This summary was generated using AI. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.
Organizations with orphan designations or approved therapies for this disease
Alnylam Pharmaceuticals, Inc.
Other
Amicus Therapeutics, Inc.
Other
Astellas Pharma Global Development, Inc.
Other
Bayer HealthCare Pharmaceuticals Inc.
Other
BeOne Medicines USA, Inc.
Other
Blueprint Medicines Corporation
Other
Bristol-Myers Squibb Company
Other
CSL Behring
Other
Celator Pharmaceuticals, Inc. (a Jazz Pharmaceuticals Company)
Other
Coherus BioSciences Inc
Other
Crinetics Pharmaceuticals, Inc.
Other
Cytokinetics Inc.
Other
Incyte Corporation
Other
Jazz Pharmaceuticals Ireland Limited
Other
MSD International Business GmbH
Other
MyoKardia, Inc. (A Wholly-Owned Subsidiary of Bristol Myers Squibb)
Other
Neurotech Pharmaceuticals, Inc.
Other
Novartis Pharmaceuticals Corporation
Other
Partner Therapeutics, Inc.
Other
Pfizer, Inc.
Other
QED Therapeutics, Inc.
Other
Stratatech Corporation, a Mallinckrodt company
Other
Teva Branded Pharmaceutical Products R&D, Inc.
Other
USWM CT, LLC
Other